Skip to main content
Signal8
Launch Terminal

ADARx Pharmaceuticals, Inc. (ADRX)

ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

ADARx Pharmaceuticals, Inc. logo

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRXIndustrials
-0.28%$17.63
AH Close$17.63+0.00%vs close
Mkt Cap$1.88B
Float52.5M
O/S106.8M
Inst Own-
SI2.2%
Dilution
ADARx Pharmaceuticals, Inc. logoNASDAQ:ADRX$17.63-0.28%
FormDescription
13G
Beneficial Ownership Report
1
13D
Beneficial Ownership Report (Active)
2
13D
Beneficial Ownership Report (Active)
3
13G
Beneficial Ownership Report
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
S-8
SEC Filing
2
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
8-K
3.02,5.03,8.01,9.01
3
424B4
Prospectus
6
EFFECT
Notice of Effectiveness
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership

1-25 of 47